|
|
Volumn 345, Issue , 2012, Pages
|
|
Final hearings begin in epic legal battle over Novartis drug in India.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
GENERIC DRUG;
IMATINIB;
PIPERAZINE DERIVATIVE;
PYRIMIDINE DERIVATIVE;
DRUG LEGISLATION;
ECONOMICS;
FEE;
HUMAN;
INDIA;
LEGAL ASPECT;
NOTE;
PATENT;
ANTINEOPLASTIC AGENTS;
DRUGS, GENERIC;
FEES, PHARMACEUTICAL;
HUMANS;
INDIA;
LEGISLATION, DRUG;
PATENTS AS TOPIC;
PIPERAZINES;
PYRIMIDINES;
|
|
EID: 84871891541
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.e6257 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
